A Randomized Comparative Study on the Effectiveness of Dexmedetomidine and Fentanyl as Adjuvants to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block
International Journal of Pharmaceutical Quality Assurance · 31.03.2026 · 17 (03)
DOI: 10.25258/ijpqa.17.3.40 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 31.03.2026. Verfasst von Priyanka Hansda und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Adjuvants are frequently added to local anesthetics to improve the efficacy of regional anesthesia and extend postoperative analgesia. Dexmedetomidine, an α2-adrenergic agonist, and fentanyl, a μ-opioid receptor agonist, are commonly used adjuvants. Their comparative effectiveness in supraclavicular brachial plexus block remains a subject of ongoing investigation.
Aim
To compare the onset, duration, and analgesic efficacy of dexmedetomidine versus fentanyl as adjuvants to 0.75% ropivacaine in ultrasound-guided supraclavicular brachial plexus block.
Methods
A randomized, prospective clinical study was conducted on 92 ASA I/II patients aged 18–60 years undergoing upper limb surgeries. Patients were divided into two groups: Group D received 0.75% ropivacaine with 1 µg/kg dexmedetomidine, and Group F received 0.75% ropivacaine with 1 µg/kg fentanyl. Block characteristics, analgesia duration, hemodynamic parameters, and adverse effects were recorded and analyzed.
Results
Group D showed significantly faster onset and prolonged duration of sensory and motor blocks, along with longer analgesia duration (736.5 ± 32.8 min vs. 654.2 ± 25.6 min, p < 0.001). Hemodynamic changes were mild and manageable in both groups.
Conclusion
Dexmedetomidine is more effective than fentanyl as an adjuvant to ropivacaine in supraclavicular brachial plexus block, offering superior block quality and extended postoperative analgesia.
Zitieren
APA
Hansda, P., & Soren, R. (2026). A Randomized Comparative Study on the Effectiveness of Dexmedetomidine and Fentanyl as Adjuvants to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block. International Journal of Pharmaceutical Quality Assurance, 17(03). https://doi.org/10.25258/ijpqa.17.3.40
Vancouver
Hansda P, Soren R. A Randomized Comparative Study on the Effectiveness of Dexmedetomidine and Fentanyl as Adjuvants to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block. International Journal of Pharmaceutical Quality Assurance. 2026;17(03). doi:10.25258/ijpqa.17.3.40
BibTeX
@article{Hansda2026,
author = {Hansda, Priyanka and Soren, Rani},
title = {A Randomized Comparative Study on the Effectiveness of Dexmedetomidine and Fentanyl as Adjuvants to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {03},
doi = {10.25258/ijpqa.17.3.40}
}
EUVIMED